Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021

SELL
$56.61 - $80.46 $1,868 - $2,655
-33 Closed
0 $0
Q1 2021

May 11, 2021

BUY
$86.23 - $125.19 $1,034 - $1,502
12 Added 57.14%
33 $3,000
Q4 2020

Feb 09, 2021

BUY
$79.17 - $111.47 $633 - $891
8 Added 61.54%
21 $2,000
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $1,064 - $1,754
13 New
13 $1,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Aua Capital Management, LLC Portfolio

Follow Aua Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aua Capital Management, LLC with notifications on news.